Nature's Sunshine Products, Inc. (NATR) Stock

Nature's Sunshine Products, Inc. (NATR) is a Healthcare stock trading at $20.05 (as of 2026-06-18), with a market capitalization of $374.21M and a trailing P/E of 19.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Nature’s Sunshine Products, Inc. develops, manufactures, and sells nutritional supplements and personal care products under the Nature’s Sunshine and Synergy WorldWide brands, reaching customers across Asia, Europe, North America, Latin America, and other international markets. Its offerings include general health categories (such as blood sugar, bone, cellular, cognitive, and joint health) as well as personal care items sold through an independent consultant sales force.

Valuation — source: SEC EDGAR (first-party)
Price	$20.05
Market Cap	$374.21M
P/E Ratio	19.3
EV / EBITDA	6.9
Price / Book	2.24
Price / Sales	0.76
DCF Value (model)	$29.00
DCF Upside vs Price	44.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$480.14M
Net Margin	4.1%
Return on Equity	11.9%
Current Ratio	2.50
Revenue Growth (YoY)	5.7%
EPS Growth (YoY)	163.4%
FCF Growth (YoY)	101.3%

Financial Health — source: SEC EDGAR
Altman Z-Score	5.14 (safe)

Valuation vs Sector & Industry
Stock P/E	19.3
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-7.4%
vs Industry	13.7%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	WYNNEFIELD CAPITAL INC ($59.34M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Kenneth G. Romanzi
Employees	819
Country	US
IPO Date	2009-06-25

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.